SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-22-013875
Filing Date
2022-04-07
Accepted
2022-04-07 17:00:22
Documents
5
Period of Report
2022-05-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A vktx-def14a_20220524.htm DEF 14A 741104
2 GRAPHIC gjwjlwxowbkl000001.jpg GRAPHIC 13741
3 GRAPHIC gjwjlwxowbkl000003.jpg GRAPHIC 48440
4 GRAPHIC gjwjlwxowbkl000004.jpg GRAPHIC 86183
5 GRAPHIC gjwjlwxowbkl000002.jpg GRAPHIC 17288
  Complete submission text file 0001564590-22-013875.txt   970839
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37355 | Film No.: 22814538
SIC: 2834 Pharmaceutical Preparations